Sonographically monitored ovarian stimulation for assisted reproduction: A prospective, blind study

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 41, Issue 1, 1996, Pages 7-10

  Confino, Edmond ^a,b   Binor, Zvi ^a   Molo, Mary Wood ^a   Rawlins, Richard ^a   Rene Balos R N ^a   Kimberly Mullaney, R N ^a   Radwanska, Ewa ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

reproduction techniques; ultrasonography

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; FEMALE INFERTILITY; HORMONE DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVAGINAL DRUG ADMINISTRATION; LUTEINIZING HORMONE RELEASE; MAJOR CLINICAL STUDY; OVARY FOLLICLE CELL; OVARY FUNCTION; PREDICTION; PREGNANCY RATE; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE;

FEMALE; FOLLICLE STIMULATING HORMONE; GONADAL STEROID HORMONES; HUMANS; MENOTROPINS; MONITORING, PHYSIOLOGIC; OVARIAN FOLLICLE; OVULATION INDUCTION; PROSPECTIVE STUDIES;

EID: 0030064098     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Muasher SJ, Garcia JE, Rosenwaks Z: The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in-vitro fertilization. Fertil Steril 1985;44:62-69
2. Forman R, Robinson J, Egan D, et al: Follicular monitoring and outcome of in-vitro fertilization in gonadotropin-releasing hormone-agonist-treated cycles. Fertil Steril 1991;55: 523-567
3. Muasher SJ, Oehninger S, Simonetti S, et al: The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in-vitro fertilization outcome. Fertil Steril 1988;50:298-307
4. Stanger JD, Yovich JL: Reduced in-vitro fertilization human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol 1985;92:385-393
5. Feldberg D, Goldman GA, Ashkenazi J, et al: The impact of high progesterone levels in the follicular phase of in-vitro fertilization (IVF) cycles: A comparative study. J IVF-ET 1989;6:11-14
6. Schoolcraft W, Sinton E, Schlenker T, et al: Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril 1991;55:563-566
7. Trounson AO, Calabrese R: Changes in plasma progesterone concentrations around the time of the luteinizing hormone surge in women superovulated for in-vitro fertilization. J Clin Endocrinol Metab 1984;59:1075-1080
8. Edelstein MC, Robinson SM, Seltman HJ, et al: Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil Steril 1990;54:853-857
9. Penzias AS, Jours EE, Seiter DB, et al: Baseline ovarian hyperstimulation for in vitro fertilization. Fertil Steril 1992;57:1017-1021
10. de Ziegler D, Cedar MI, Randle D, et al: Suppression of the ovary using a gonadotropin-releasing hormone agonist prior to stimulation for oocyte retrieval. Fertil Steril 1987;48:807-810
11. Droesch K, Muasher SJ, Brzynski RG, et al: Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril 1989;51:292-297
12. Nilsson L, Wikland M, Hamberger L, et al: Simplification of the method of in vitro fertilization: Sonographic measurements of follicular diameter as the sole index of follicular maturity. J IVF-ET 1985;2:17-20